Suppr超能文献

通过用表达淋巴细胞性脉络丛脑膜炎病毒(LCMV-WE)核蛋白或糖蛋白的痘苗重组病毒免疫,对小鼠进行抗病毒保护并预防淋巴细胞性脉络丛脑膜炎或局部足垫肿胀反应。

Anti-viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia-recombinant virus expressing LCMV-WE nucleoprotein or glycoprotein.

作者信息

Hany M, Oehen S, Schulz M, Hengartner H, Mackett M, Bishop D H, Overton H, Zinkernagel R M

机构信息

Institute of Pathology, University Hospital, Zürich, Switzerland.

出版信息

Eur J Immunol. 1989 Mar;19(3):417-24. doi: 10.1002/eji.1830190302.

Abstract

The viral antigen specificity of primary cytotoxic T cell responses (CTL) of H-2b, H-2k, H-2q, H-2s, H-2f and some H-2-recombinant mice against lymphocytic choriomeningitis virus (LCMV-WE isolate) as well as the specificity of some CTL clones and T cell lines was defined on target cells infected with vaccinia-recombinant virus expressing nucleoprotein (Np) or glycoprotein (Gp). Np was recognized together with H-2q (Dq), H-2d (DLd), H-2s and H-2b (Db). Gp specificity was restricted to H-2f and H-2b (Kb and Db); H-2k-restricted CTL anti-LCMV responses were neither Gp nor Np specific. The anti-viral protective immunity induced by vaccinia-Gp or vaccinia-Np recombinants was evaluated in mice. In vivo protection was T cell mediated by class I restricted Ly-2+ T cells; it correlated well with the CTL specificity defined in vitro. Some of the CTL-nonresponder H-2 allele plus Np or H-2 plus Gp combinations were, however, protected to variable and low degrees by vaccinia-recombinant viruses, indicating that anti-viral protection is a more sensitive readout for CTL activity than the in vitro assay. For example, B10.D2 H-2d mice generated measurable CTL responses only to Np; after immunization with a vaccinia-Np recombinant, LCMV titers were 10(4) times lower in spleens than in vaccinia-primed controls. Although vaccinia-Gp-immunized BALB/c mice revealed no CTL activity in vitro, they nevertheless had 10(2) times lower LCMV titers in spleens than controls. Anti-viral protection, particularly in low-responder combinations, was usually short-lived and diminished after 3 weeks. In a high-responder situation, protection was of a longer duration (greater than 8 weeks). Vaccination with vaccinia-Np or Gp recombinants protected mice against lethal T cell-mediated lymphocytic choriomeningitis induced by LCMV or prevented the local footpad swelling reaction; these in vivo effects were H-2 dependent and followed the identical roles established for CTL recognition in vitro.

摘要

对感染了表达核蛋白(Np)或糖蛋白(Gp)的痘苗重组病毒的靶细胞,定义了H-2b、H-2k、H-2q、H-2s、H-2f以及一些H-2重组小鼠针对淋巴细胞性脉络丛脑膜炎病毒(LCMV-WE分离株)的原发性细胞毒性T细胞应答(CTL)的病毒抗原特异性,以及一些CTL克隆和T细胞系的特异性。Np与H-2q(Dq)、H-2d(DLd)、H-2s和H-2b(Db)共同被识别。Gp特异性仅限于H-2f和H-2b(Kb和Db);H-2k限制性CTL抗LCMV应答既不是Gp特异性也不是Np特异性。在小鼠中评估了痘苗-Gp或痘苗-Np重组体诱导的抗病毒保护性免疫。体内保护是由I类限制性Ly-2 + T细胞介导的T细胞介导的;它与体外定义的CTL特异性密切相关。然而,一些CTL无应答的H-2等位基因加Np或H-2加Gp组合,受到痘苗重组病毒不同程度的低水平保护,这表明抗病毒保护比体外测定是更灵敏的CTL活性读数。例如,B10.D2 H-2d小鼠仅对Np产生可测量的CTL应答;用痘苗-Np重组体免疫后,脾脏中的LCMV滴度比痘苗预免疫对照低10^4倍。尽管用痘苗-Gp免疫的BALB/c小鼠在体外未显示CTL活性,但它们脾脏中的LCMV滴度仍比对照低10^2倍。抗病毒保护,特别是在低应答组合中,通常是短暂的,3周后减弱。在高应答情况下,保护持续时间更长(超过8周)。用痘苗-Np或Gp重组体接种可保护小鼠免受LCMV诱导的致死性T细胞介导的淋巴细胞性脉络丛脑膜炎,或预防局部足垫肿胀反应;这些体内效应是H-2依赖性的,并遵循体外CTL识别所确立的相同规律。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验